PICTON MAHONEY ASSET MANAGEMENT

Position in ZYME — Zymeworks Inc.

CIK 1539041 Toronto, A6

Position in ZYME

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,427,517

-$18,014 QoQ

Shares Held

256,690

+4.9% QoQ

Ownership

0.352%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PICTON MAHONEY ASSET MANAGEMENT holds $87,092,186 across 24 Biotechnology names. ZYME ranks #5 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,330,842	$19,243,975
2	ACLX	Arcellx, Inc.	120,000	$13,778,400
3	REGN	Regeneron Pharmaceuticals, Inc.	15,408	$11,904,837
4	MIRM	Mirum Pharmaceuticals, Inc.	74,118	$6,847,020
5	ZYME	Zymeworks Inc. This page	256,690	$6,427,517
6	APLS	Apellis Pharmaceuticals, Inc.	150,000	$6,034,500
7	TERN	Terns Pharmaceuticals, Inc.	100,000	$5,272,000
8	CAI	Caris Life Sciences, Inc.	278,977	$4,988,108

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,427,517	256,690	+4.9%	Shares	Sole	2026-05-13
2025-12-31	$6,445,531	244,798	+18.6%	Shares	Sole	2026-02-11
2025-09-30	$3,523,979	206,322	-0.6%	Shares	Sole	2025-11-12
2025-06-30	$2,605,405	207,602	-0.2%	Shares	Sole	2025-08-12
2025-03-31	$2,477,625	208,029	+0.7%	Shares	Sole	2025-05-07
2024-12-31	$3,024,170	206,569	-15.6%	Shares	Sole	2025-04-02
2024-09-30	$3,070,432	244,656	-0.0%	Shares	Sole	2024-11-04
2024-06-30	$2,082,890	244,758	-13.9%	Shares	Sole	2024-07-31
2024-03-31	$2,991,656	284,378	-20.3%	Shares	Sole	2024-05-09
2023-12-31	$3,708,253	356,906	-0.5%	Shares	Sole	2024-02-06
2023-09-30	$2,274,906	358,818	+2.5%	Shares	Sole	2023-11-06
2023-06-30	$3,025,416	350,164	+10.3%	Shares	Sole	2023-08-03
2023-03-31	$2,870,380	317,520	+22.6%	Shares	Sole	2023-05-08
2022-12-31	$2,035,771	259,004	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.